Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SOARA: Safety in Ovarian Cancer for Average-Risk Women - Analysis Clinical Validation Protocol

NCT07872644 is registered in ClinicalTrials.gov with Mercy BioAnalytics, Inc. as lead sponsor.

NCT NCT07872644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07872644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SOARA: Safety in Ovarian Cancer for Average-Risk Women - Analysis Clinical Validation Protocol
Lead sponsor
Mercy BioAnalytics, Inc.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
May 31, 2028
Enrollment
1,750 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer